Deciphera Pharmaceuticals Inc.(DCPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DCPH Deciphera Pharmaceuticals Inc.

停牌 06-10 16:00:00 EDT

25.59

+0.00

0.00%

最高25.59	最低25.59	成交量0.00
今开25.59	昨收25.59	日振幅0.00%
总市值22.13亿	流通市值11.88亿	总股本8,648万
成交额4,084万	换手率0.00%	流通股本4,643万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DCPH","market":"US","secType":"STK","nameCN":"Deciphera Pharmaceuticals Inc.","latestPrice":25.59,"timestamp":1718049600000,"preClose":25.59,"halted":3,"volume":0,"delay":0,"floatShares":46427427,"shares":86475972,"eps":-2.212229,"marketStatus":"停牌","marketStatusCode":0,"change":0,"latestTime":"06-10 16:00:00 EDT","open":25.59,"high":25.59,"low":25.59,"amount":40838133.283464,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.212229,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1506571200000,"adjPreClose":25.59,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/DCPH","defaultTab":"news","newsList":[{"id":"2434859606","title":"Deciphera Pharmaceuticals(DCPH.US)：2024年Q1财报实现营收4499.9万美元，前值为3344.","url":"https://stock-news.laohu8.com/highlight/detail?id=2434859606","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434859606?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:19","pubTimestamp":1715347188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","DCPH"],"gpt_icon":0},{"id":"2432374534","title":"摩根大通证券公司：下调Deciphera Pharmaceuticals(DCPH.US)评级，由优于大市调整至大市一致评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432374534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432374534?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:58","pubTimestamp":1714579127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["399975","BK4139","DCPH","159848"],"gpt_icon":0},{"id":"2431369005","title":"日本小野制药公司称 24 亿美元收购 Deciphera 是全球扩张的 \"第一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2431369005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431369005?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:41","pubTimestamp":1714462881,"startTime":"0","endTime":"0","summary":" Rocky Swift    路透东京4月30日 - 日本小野制药公司  周二表示，它以24亿美元收购Deciphera Pharmaceuticals  是拓展美国和欧洲市场的 \"第一步\"。该药预计将从 2028 年起在主要市场失去专利保护。此次收购包括Deciphera公司用于治疗一种胃肠道癌症的口服药物Qinlock，该药于2020年获得美国食品和药物管理局的全面批准。数字Ono Pharma 的现金收购价为每股 25.60 美元，比总部位于美国的 Deciphera 之前的收盘价溢价 74.7%。Deciphera股价则大涨73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","BMY","LU0061475181.USD","IE00BSNM7G36.USD","BK4139","LU0456855351.SGD","BK4585","LU0868494617.USD","IE0009355771.USD","IE0002141913.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","BK4534","LU1718418525.SGD","LU1670710661.SGD","LU1430594728.SGD","LU1032466523.USD","LU0321505439.SGD","IE00BFTCPJ56.SGD","LU2360032135.SGD","BK4588","BK4532","LU1571399168.USD","LU1670710588.SGD","LU0882574055.USD","LU1585245621.USD","LU1989771016.USD","LU2125154935.USD","LU0237698245.USD","IE00B2B36J28.USD","LU2125154778.USD","LU2242652126.USD","BK4559","LU1261432733.SGD","IE00BJT1NW94.SGD","LU0321505868.SGD","BK4007","LU0114720955.EUR","DCPH","LU1670711040.USD","BK4581","LU2242646821.SGD","LU1670711123.USD","LU1291159041.SGD"],"gpt_icon":0},{"id":"2431899174","title":"Deciphera Pharmaceuticals Inc    预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431899174","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431899174?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:36","pubTimestamp":1714404960,"startTime":"0","endTime":"0","summary":"   * Deciphera Pharmaceuticals Inc    预计将在5月1日公布截至2024年3月31日的业绩()，季度收入将有所增长。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆的公司的营收预计将从去年同期的3345万美元增长38.5%，达到4630.7万美元。* LSEG分析师对Deciphera Pharmaceuticals Inc的平均预期是每股亏损55美分。* 华尔街对 Deciphera Pharmaceuticals Inc 的 12 个月目标价中位数为 24.50 美元，高于其上次收盘价 14.65 美元。4月29日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCPH"],"gpt_icon":0},{"id":"2431896744","title":"JonesTrading：下调Deciphera Pharmaceuticals(DCPH.US)评级，由买入调整至持有评级, 目标价25.60美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431896744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431896744?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:25","pubTimestamp":1714404350,"startTime":"0","endTime":"0","summary":"JonesTrading：下调Deciphera Pharmaceuticals(DCPH.US)评级，由买入调整至持有评级, 目标价25.60美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923255287bff911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923255287bff911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCPH"],"gpt_icon":0},{"id":"2431661318","title":"Deciphera Pharmaceuticals, Inc.股价上涨72.15% 市值涨14.96亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431661318","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431661318?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397469,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Deciphera Pharmaceuticals, Inc.股票出现波动，股价急速上涨72.15%。Deciphera Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.21%。Deciphera Pharmaceuticals, Inc.公司简介：Deciphera Pharmaceuticals Inc是一家生物技术公司，开发和生产用于治疗癌症和免疫性疾病的激酶抑制药物。消息层面，截至21时31分，《Deciphera盘前大涨71% 获小野药品工业溢价收购》资讯为影响Deciphera Pharmaceuticals, Inc.的重要信息。受此消息提振，截至发稿，Deciphera 盘前大涨71%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921310987bf99a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921310987bf99a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DCPH"],"gpt_icon":0},{"id":"2431857365","title":"Deciphera盘前大涨71%！获小野药品工业溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2431857365","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431857365?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:58","pubTimestamp":1714395491,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Deciphera Pharmaceuticals周一宣布，日本小野药品工业已同意以24亿美元的总股本价值收购这家癌症药物开发商。受此消息提振，截至发稿，Deciphera 盘前大涨71%。相比Deciphera 2024年4月26日的收盘价，其收购价溢价了74.7%。此次收购获得了两家公司董事会的批准，通过要约收购，Deciphera将与小野药品工业的全资子公司合并。合并完成后，Deciphera将作为小野药品集团的独立业务运营，总部设在马萨诸塞州沃尔瑟姆。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115046.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","DCPH"],"gpt_icon":1},{"id":"2431857330","title":"【Deciphera(DCPH.US)盘前大涨71% 获小野药品工业溢价收购】智通财经APP获悉，Deciphera Pharmaceuticals(DCPH.","url":"https://stock-news.laohu8.com/highlight/detail?id=2431857330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431857330?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:58","pubTimestamp":1714395491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DCPH","BK4007","BK4139","OPHLY"],"gpt_icon":0},{"id":"2431832050","title":"更新版 1-日本小野制药公司将以 24 亿美元收购 Deciphera 公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2431832050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431832050?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:18","pubTimestamp":1714389504,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第2段增加了交易细节)    路透4月29日 - Deciphera Pharmaceuticals   周一称，日本小野制药公司  将以24亿美元现金收购这家癌症药物开发商。小野制药的报价为每股25.60美元，比这家美国公司的最后收盘价14.65美元高出74.7%。 目前，Deciphera 的股票盘前交易已经停止。Deciphera公司表示，此次收购预计将于2024年第三季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCPH","BK4139"],"gpt_icon":0},{"id":"2431625834","title":"日本 ONO 制药公司将以 24 亿美元收购 Deciphera 公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2431625834","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431625834?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:06","pubTimestamp":1714388791,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透4月29日 - Deciphera Pharmaceuticals   周一表示，日本ONO Pharmaceutical Co   将以24亿美元现金收购该公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCPH","BK4139"],"gpt_icon":0},{"id":"2423142167","title":"Deciphera Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.01%报15.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423142167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2423142167?lang=zh_cn&edition=full","pubTime":"2024-03-29 02:29","pubTimestamp":1711650573,"startTime":"0","endTime":"0","summary":"北京时间2024年03月29日02时29分，Deciphera Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报15.94美元/股，成交量25.1977万股，换手率0.31%，振幅4.38%。Deciphera Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.43%。Deciphera Pharmaceuticals, Inc.公司简介：Deciphera Pharmaceuticals Inc是一家生物技术公司，开发和生产用于治疗癌症和免疫性疾病的激酶抑制药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240329022933861e232b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240329022933861e232b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BFRI","BK4007","DCPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.deciphera.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0043},{"period":"1year","weight":1.1044},{"period":"ytd","weight":0.5865}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Deciphera Pharmaceuticals, Inc.是一家生物制药公司，专注于发现，开发和提供重要的新药给病人治疗癌症。该公司正在利用其专有的开关控制激酶抑制剂平台和激酶生物学的深厚专业知识来执行他们的战略，以开发广泛的创新药物组合。该公司有一种已获批准的药物，秦洛克，这是通过他们的专有平台开发的。除了秦洛克，该公司正在开发三种临床阶段的候选药物，并推进其研究阶段的项目。公司完全拥有秦洛克及其所有候选药物，但秦洛克在大中华区的开发和商业化许可协议除外。公司正准备在欧洲推出QINLOCK，公司已签订并打算在未来签订选定的经销商协议，以便在公司不打算自行分销QINLOCK的地区（如澳大利亚和加拿大）提供QINLOCK。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.000538},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.029664},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.053422},{"month":4,"riseRate":0.714286,"avgChangeRate":0.167294},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.013141},{"month":6,"riseRate":0.857143,"avgChangeRate":0.125832},{"month":7,"riseRate":0,"avgChangeRate":-0.101869},{"month":8,"riseRate":0.833333,"avgChangeRate":0.173023},{"month":9,"riseRate":0.666667,"avgChangeRate":0.041099},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032519},{"month":11,"riseRate":0.714286,"avgChangeRate":-0.036004},{"month":12,"riseRate":0.714286,"avgChangeRate":0.089663}],"exchange":"NASDAQ","name":"Deciphera Pharmaceuticals Inc.","nameEN":"Deciphera Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Deciphera Pharmaceuticals Inc.(DCPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Deciphera Pharmaceuticals Inc.(DCPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Deciphera Pharmaceuticals Inc.,DCPH,Deciphera Pharmaceuticals Inc.股票,Deciphera Pharmaceuticals Inc.股票老虎,Deciphera Pharmaceuticals Inc.股票老虎国际,Deciphera Pharmaceuticals Inc.行情,Deciphera Pharmaceuticals Inc.股票行情,Deciphera Pharmaceuticals Inc.股价,Deciphera Pharmaceuticals Inc.股市,Deciphera Pharmaceuticals Inc.股票价格,Deciphera Pharmaceuticals Inc.股票交易,Deciphera Pharmaceuticals Inc.股票购买,Deciphera Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Deciphera Pharmaceuticals Inc.(DCPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Deciphera Pharmaceuticals Inc.(DCPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}